BACKGROUND: Galactosyl transferase gene knock-out (GalTKO) swine offer a unique tool to evaluate the role of the Gal antigen in xenogenic lung hyperacute rejection. METHODS: We perfused GalTKO miniature swine lungs with human blood. Results were compared with those from previous studies using wild-type and human decay-accelerating factor-transgenic (hDAF(+/+) ) pig lungs. RESULTS: GalTKO lungs survived 132 ± 52 min compared to 10 ± 9 min for wild-type lungs (P = 0.001) and 45 ± 60 min for hDAF(+/+) lungs (P = 0.18). GalTKO lungs displayed stable physiologic flow and pulmonary vascular resistance (PVR) until shortly before graft demise, similar to autologous perfusion, and unlike wild-type or hDAF(+/+) lungs. Early (15 and 60 min) complement (C3a) and platelet activation and intrapulmonary platelet deposition were significantly diminished in GalTKO lungs relative to wild-type or hDAF(+/+) lungs. However, GalTKO lungs adsorbed cytotoxic anti-non-Gal antibody and elaborated high levels of thrombin; their demise was associated with increased PVR, capillary congestion, intravascular thrombi and strong CD41 deposition not seen at earlier time points. CONCLUSIONS: In summary, GalTKO lungs are substantially protected from injury but, in addition to anti-non-Gal antibody and complement, platelet adhesion and non-physiologic intravascular coagulation contribute to Gal-independent lung injury mechanisms.
BACKGROUND:Galactosyl transferase gene knock-out (GalTKO) swine offer a unique tool to evaluate the role of the Gal antigen in xenogenic lung hyperacute rejection. METHODS: We perfused GalTKO miniature swine lungs with human blood. Results were compared with those from previous studies using wild-type and human decay-accelerating factor-transgenic (hDAF(+/+) ) pig lungs. RESULTS: GalTKO lungs survived 132 ± 52 min compared to 10 ± 9 min for wild-type lungs (P = 0.001) and 45 ± 60 min for hDAF(+/+) lungs (P = 0.18). GalTKO lungs displayed stable physiologic flow and pulmonary vascular resistance (PVR) until shortly before graft demise, similar to autologous perfusion, and unlike wild-type or hDAF(+/+) lungs. Early (15 and 60 min) complement (C3a) and platelet activation and intrapulmonary platelet deposition were significantly diminished in GalTKO lungs relative to wild-type or hDAF(+/+) lungs. However, GalTKO lungs adsorbed cytotoxic anti-non-Gal antibody and elaborated high levels of thrombin; their demise was associated with increased PVR, capillary congestion, intravascular thrombi and strong CD41 deposition not seen at earlier time points. CONCLUSIONS: In summary, GalTKO lungs are substantially protected from injury but, in addition to anti-non-Gal antibody and complement, platelet adhesion and non-physiologic intravascular coagulation contribute to Gal-independent lung injury mechanisms.
Authors: Z E Holzknecht; S Coombes; B A Blocher; T B Plummer; M Bustos; C L Lau; R D Davis; J L Platt Journal: Am J Pathol Date: 2001-02 Impact factor: 4.307
Authors: Richard N Pierson; Anthony Dorling; David Ayares; Michael A Rees; Jörg D Seebach; Jay A Fishman; Bernhard J Hering; David K C Cooper Journal: Xenotransplantation Date: 2009 Sep-Oct Impact factor: 3.907
Authors: L Burdorf; T Stoddard; T Zhang; E Rybak; A Riner; C Avon; A Laaris; X Cheng; E Sievert; G Braileanu; A Newton; C J Phelps; D Ayares; A M Azimzadeh; R N Pierson Journal: Am J Transplant Date: 2014-04-02 Impact factor: 8.086
Authors: Beth M French; Selin Sendil; Krishna Mohan Sepuru; Jolene Ranek; Lars Burdorf; Donald Harris; Emily Redding; Xiangfei Cheng; Christopher T Laird; Yuming Zhao; Benjamin Cerel; Krishna Rajarathnam; Richard N Pierson; Agnes M Azimzadeh Journal: Xenotransplantation Date: 2018-02-09 Impact factor: 3.907
Authors: David K C Cooper; Burcin Ekser; Christopher Burlak; Mohamed Ezzelarab; Hidetaka Hara; Leela Paris; A Joseph Tector; Carol Phelps; Agnes M Azimzadeh; David Ayares; Simon C Robson; Richard N Pierson Journal: Xenotransplantation Date: 2012 May-Jun Impact factor: 3.907
Authors: Donald G Harris; Kevin J Quinn; Siamak Dahi; Lars Burdorf; Agnes M Azimzadeh; Richard N Pierson Journal: Xenotransplantation Date: 2014-07-05 Impact factor: 3.907
Authors: P Thompson; I R Badell; M Lowe; A Turner; J Cano; J Avila; A Azimzadeh; X Cheng; R N Pierson; B Johnson; J Robertson; M Song; F Leopardi; E Strobert; G Korbutt; G Rayat; R Rajotte; C P Larsen; A D Kirk Journal: Am J Transplant Date: 2012-03-28 Impact factor: 8.086
Authors: Jenna L Balestrini; Ashley L Gard; Kristin A Gerhold; Elise C Wilcox; Angela Liu; Jonas Schwan; Andrew V Le; Pavlina Baevova; Sashka Dimitrievska; Liping Zhao; Sumati Sundaram; Huanxing Sun; Laure Rittié; Rachel Dyal; Tom J Broekelmann; Robert P Mecham; Martin A Schwartz; Laura E Niklason; Eric S White Journal: Biomaterials Date: 2016-06-16 Impact factor: 12.479
Authors: Agnes M Azimzadeh; Guerard W Byrne; Mohamed Ezzelarab; Emily Welty; Gheorghe Braileanu; Xiangfei Cheng; Simon C Robson; Christopher G A McGregor; David K C Cooper; Richard N Pierson Journal: Xenotransplantation Date: 2014-09-01 Impact factor: 3.907